Another piece falling in to place. Amazing animal studies, IP sewn up. 11 mil in bank. Pre-clinical in Q3 last step before the Phase 1 which will capture an efficacy signal. Can't pre-empt results but with a market cap of 25 mil, surely it can do many multiples if the gear works. Over the next 2 quarters, seems like a great opportunity to buy more tickets to the show.
NYR Price at posting:
16.5¢ Sentiment: Buy Disclosure: Held
